Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Vibeke Bråthen Buljovcic"'
Autor:
Karl Trygve Druckrey-Fiskaaen, Einar Furulund, Tesfaye Madebo, Siv-Elin Leirvåg Carlsen, Lars T. Fadnes, Torgeir Gilje Lid, for ATLAS4LAR Study Group, Vibeke Bråthen Buljovcic, Jan Tore Daltveit, Trude Fondenes, Per Gundersen, Beate Haga Trettenes, Mette Hegland Nordbotn, Maria Olsvold, Marianne Cook Pierron, Christine Sundal, Jørn Henrik Vold, Maren Borsheim Bergsaker, Eivin Dahl, Tone Lise Eielsen, Torhild Fiskå, Marianne Larssen, Eirik Holder, Ewa Joanna Wilk, Mari Thoresen Soot
Publikováno v:
Frontiers in Psychiatry, Vol 14 (2023)
IntroductionSmoking-related diseases are major contributors to disability and shorter life expectancy among opioid-dependent patients. Smoking prevalence is considerably higher for opioid-dependent persons than among the general population, and only
Externí odkaz:
https://doaj.org/article/1eb790fdbc254820965bb5e36bf45734
Autor:
Ole Jørgen Lygren, Ronny Bjørnestad, Else-Marie Løberg, Martine Lepsøy Bonnier, Vibeke Bråthen Buljovcic, Kjell Arne Johansson, Lars T. Fadnes, for the INTRO-HCV Study Group
Publikováno v:
Substance Abuse Treatment, Prevention, and Policy, Vol 14, Iss 1, Pp 1-7 (2019)
Abstract Background For people with opioid dependence in Norway, chronic hepatitis C virus (HCV) infections contribute to high mortality and high morbidity. Around 50% of patients in medically assisted rehabilitation (MAR) have been shown to have HCV
Externí odkaz:
https://doaj.org/article/5a16a4be7aba43afa5d5e2284d4bd3a6
Autor:
Kjell Arne Johansson, Vibeke Bråthen Buljovcic, Martine Bonnier, Ole Jørgen Scheie Lygren, Else-Marie Løberg, Lars Thore Fadnes, Ronny Bjørnestad
Publikováno v:
Substance Abuse Treatment, Prevention, and Policy
Substance Abuse Treatment, Prevention, and Policy, Vol 14, Iss 1, Pp 1-7 (2019)
Substance Abuse Treatment, Prevention, and Policy, Vol 14, Iss 1, Pp 1-7 (2019)
Background For people with opioid dependence in Norway, chronic hepatitis C virus (HCV) infections contribute to high mortality and high morbidity. Around 50% of patients in medically assisted rehabilitation (MAR) have been shown to have HCV, and the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0fd76af559463a03e7df3268c1662d7b
https://doi.org/10.1186/s13011-019-0245-y
https://doi.org/10.1186/s13011-019-0245-y